Jace Jianxin HUANG
Questioner · DISC type cJace Jianxin Huang is the Senior Director of Oncology Early Commercial & Portfolio Strategy at GSK, with deep expertise in leading global product launches across the U. S. , Europe, and China. He holds dual MBAs from HEC Paris and Georgetown University and is certified in European Pharma Market Access.
He has a strong interest in technologys role in healthcare, particularly the application of AI in diagnosing rare cancers and diseases. He is also passionate about improving patient access to medication and has voiced concerns about drug affordability.
At his previous role at Ipsen, he led the commercial assessment for the license-in of Elafibrarnor, which was the companys largest transaction.
Read the full overview →How Jace shows up
They prefer to analyze every situation thoroughly. They are more likely than others to negotiate on pricing and terms. They generally do not appreciate an overfriendly approach and prefer to stay to-the-point.
Topics Jace cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Other GSK Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.